Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens.
about
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysisStandardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysisEffectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort studyRe-treatment tuberculosis cases categorised as "other": are they properly managed?The Role of Adherence and Retreatment in De Novo Emergence of MDR-TBMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisAlcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment - data from ten years' observation at the Regional Centre of Pulmonology, Bydgoszcz, PolandDrug-resistant tuberculosis: a worldwide epidemic poses a new challengeEpidemiology and treatment of multidrug resistant tuberculosisRisk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in MoroccoA retrospective case-control study, factors affecting treatment outcomes for pulmonary tuberculosis in istanbul, TurkeyEarly results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon.Rates and risk factors for drug resistance tuberculosis in Northeastern ChinaDevelopment of new vaccines and drugs for TB: limitations and potential strategic errorsEffect of universal MODS access on pulmonary tuberculosis treatment outcomes in new patients in PeruTuberculosis chemotherapy in the 21 century: Back to the basics.Treatment of drug-resistant tuberculosis.An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia.Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model.Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South AfricaPreventing nosocomial MDR TB transmission in sub Saharan Africa: where are we at?Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.Update in tuberculosis 2008.Plumbagin analogs-synthesis, characterization, and antitubercular activity.Drug-resistant tuberculosis: an insurmountable epidemic?Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model.Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response.Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.The global health threat of African urban slums: the example of urban tuberculosis
P2860
Q28476120-05FF4DB1-A39D-4007-8E87-B8FC2121A5A8Q28476125-411DF93B-BE66-4C6D-B3DB-D612245DF125Q28477435-AD653A71-8C9A-44DE-80B3-D4B5C4A545DCQ28478395-D2059494-54BD-43BA-BBC2-F7550A6D2691Q28550707-5A53C99E-78F4-4EF1-99E7-AA26B47A105FQ29247878-8D546B8A-F2BB-43A5-A595-945E8F01DF99Q30780403-9228F0B7-F8CD-4590-8966-2CE271EDF2FFQ33595284-C7487D71-6A7F-4C5A-AF13-AD2E7CAA7597Q33710690-AEC5DA74-D318-4A25-850C-9EEF39D94BA0Q33830959-65E741C9-84A9-40C7-953F-7CCDD3E0542AQ33974241-8810E8D1-D884-4B7F-99F3-403BC319C7BEQ34205098-A6EE307C-5F4B-4374-89C2-24DD04CEF491Q35065297-F5AD0A11-5635-462F-9D93-95E3A86BFC72Q35065531-9A0623EC-BCFF-4D8D-8359-ADF24C7E97BEQ35104409-962B5119-659A-44C5-8633-76B8DAE3D5AAQ35183890-8C04C2E4-C6E6-42E1-969A-21DE2064E47AQ35187176-E6ED8193-FD06-4CA2-9431-7A37E1104A86Q35634121-7CB69624-1695-443F-829E-12BC1522ACDAQ35681236-7A0E323A-109E-48CC-9D29-C79867F8FB96Q35914813-DB08FC00-E371-4A8C-A5EE-19178AFDCDC8Q36347436-2412EDA6-B2AE-4EBA-89CD-ED8C507BE9D1Q36555280-976FDD51-07D3-4DFC-9ACA-E97DBB57E22EQ36647864-57EF1B44-8044-4FF4-875D-DF8CFF742EAEQ36957252-BDBA4A76-450A-47D2-9E5C-9A91EC51BF98Q37398528-5BC4C16A-C2F2-4FA5-AECC-FBF6B82830EEQ37651200-C9C33FA7-DA98-4C8F-B0D9-D7A0EDC47670Q37815427-2E37080C-60E1-49D2-A5F3-401ECDE7551EQ38842946-A23FDEEE-931C-4245-AB6A-293BB00EDA45Q39192734-66746CF8-6A4F-44B2-96D1-CE57967CD3D9Q43092099-ADB84D28-3208-44D3-BF11-B24F540E9F13Q46271082-9743C1ED-3852-4DCE-9DF1-F0E283DB4C8BQ58262181-8BB74EE1-58CC-4B2F-9447-C6DB991094FE
P2860
Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Influence of multidrug resista ...... es with standardized regimens.
@en
Influence of multidrug resista ...... es with standardized regimens.
@nl
type
label
Influence of multidrug resista ...... es with standardized regimens.
@en
Influence of multidrug resista ...... es with standardized regimens.
@nl
prefLabel
Influence of multidrug resista ...... es with standardized regimens.
@en
Influence of multidrug resista ...... es with standardized regimens.
@nl
P2093
P2860
P1476
Influence of multidrug resista ...... es with standardized regimens.
@en
P2093
Adam Thomas
Mirtha Del Granado
Nigor Mouzafarova
Richard Zaleskis
P2860
P304
P356
10.1164/RCCM.200802-240OC
P407
P50
P577
2008-05-29T00:00:00Z